Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important and evolving form of insulin delivery, which is mainly used for people with type 1 diabetes.

Diabetes management has come a long way ... Furthermore, it is claimed that “The pump mimics the way the body normally ...

Krista Llewellyn was diagnosed with Type 1 diabetes at 12 years old, but she hasn’t let managing her blood sugar levels stop ...

Insulin pumps dose insulin throughout the day to help people with diabetes keep their glucose levels in target. It's a common misconception that people with diabetes who use a pump "have it ...

Over 90% of type 2 diabetes patients face an increased risk of heart disease due to high blood sugar's impact on blood ...

PharmaSens announced today that it appointed Dr. Robert A. Gabbay and James L. Peterson to its board of directors.

"This may result in the pump stopping insulin delivery significantly sooner ... serious adverse health consequences like hyperglycemia, diabetic ketoacidosis, or death. There have been 170 reports ...

Medtronic, which has operational headquarters in Fridley, has recalled 24,595 battery-operated pumps ... of diabetes that occurs when the body doesn’t have enough insulin. Class I recalls ...

The rising popularity of the continuous glucose monitor, which is not the same as an insulin pump, has been a huge advance in ...

Tandem Diabetes Care, Inc. (NASDAQ ... was largely attributed to the successful launch of the company's Mobi insulin pump system. The Mobi launch has been a significant driver of growth for ...

Over 90% of patients with type 2 diabetes have high chances of heart disease. This is because high blood sugar due to ...